SToP Cancer SPORE: Career Enhancement Program
SToP Cancer SPORE: Career Enhancement Program
批准号:
10334089
负责人:
Jonathan S. Serody
金额:
$8.48万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-16 至 2027-08-31
关键词:
Advisory CommitteesAdvocateAfrican AmericanAreaAwardBasic ScienceClinicClinicalClinical InvestigatorClinical SciencesCollaborationsCommunitiesComprehensive Cancer CenterDiagnosisDisabled PersonsDoctor of PhilosophyEarly DiagnosisFacultyFinancial SupportFosteringFundingFunding MechanismsGoalsGrantHistorically Black Colleges and UniversitiesImmunologyIndividualInstitutionJordanLaboratoriesLatino PopulationMalignant NeoplasmsMalignant neoplasm of pancreasMedicineMelissaMentorsMicrobiologyMinorityMinority WomenNorth CarolinaPancreasPatient CarePatientsPediatric Surgical ProceduresPeer ReviewPopulation SciencesPostdoctoral FellowPreventionProcessPublic HealthResearchResearch PersonnelResourcesStudentsTeacher Professional DevelopmentTranslatingTranslational ResearchUnderrepresented MinorityUniversitiesVocational GuidanceWomanWorkWritinganticancer researchbasecareercareer developmentimproved outcomemembernext generationpancreatic cancer patientsprofessorprogramsrecruitstandard caresuccesstranslational pipelinetranslational progresstranslational scientist
中文摘要
职业提升计划:摘要
胰腺孢子的职业提升计划(CEP)的主要目标是增加
一个多元化的教师群体谁将专注于胰腺癌研究的职业发展。
这将通过以下方式实现:(1)提供财政支持,以发展和加强这些机构的研究工作;
教师和2)为新进入该领域的研究人员提供临床和实验室指导。我们
旨在促进胰腺癌翻译研究人员的研究事业。卓越医療中心将
从胰腺癌转化研究的整个领域中选择研究者提供支持;包括
在预防和早期发现、诊断等公共卫生领域和其他相关领域工作的人
人口科学;基础科学研究人员致力于将他们的发现转化为诊所的病人护理,
翻译/临床研究人员致力于改善胰腺癌患者的预后。我们将
支持高素质的研究人员谁是新的胰腺癌领域的重点是早期的职业生涯
或职业生涯中期的调查人员过渡到这一领域工作。
CEP由Lineberger翻译科学副主任Jonathan Serody MD领导
综合癌症中心和伊丽莎白托马斯医学,微生物学和免疫学教授。
共同领导人得到由共同领导人主持的临选会咨询委员会的支持,
包括Melissa Troester博士(人口科学),Anne Menkens博士(行政管理),Antonio Baines
博士(CEP少数民族顾问,NCCU),Albert Baldwin博士(DRP主任)和Andrea Hayes-Jordan(儿科
手术)和我们的病人倡导者。申请人将从高素质的研究人员中选出,
北卡罗来纳州查佩尔山和北卡罗来纳州中央大学是一所历史悠久的黑人学院,
北卡罗来纳州达勒姆大学与Lineberger综合癌症研究所有着密切的科学关系。
中心,并有大量的非裔美国人和拉丁美洲人口的学生和博士后研究员。招聘
代表性不足的少数民族,残疾人和妇女的胰腺研究将得到强调,
将是贝恩斯博士在CEPAC的工作重点
财政支持将为一年的初始期,这将是可再生的,如果有适当的
翻译进展我们将与伙伴机构合作,加强多机构合作,
随着CEP的成熟,
英文摘要
CAREER ENHANCEMENT PROGRAM: ABSTRACT
The primary objective of the Career Enhancement Program (CEP) of the UNC Pancreas SPORE is to augment
the career development of a diverse group of faculty members who will focus on pancreatic cancer research.
This will be accomplished by 1) providing financial support to develop and enhance the research effort of these
faculty and 2) to provide both clinical and laboratory mentoring for investigators who are new to the field. We
intend to foster the research careers of translational investigators working in pancreatic cancer. The CEP will
select investigators for support from the entire spectrum of translational research in pancreatic cancer; including
those working in public health areas of prevention and early detection, diagnosis and other pertinent areas of
population science; basic science investigators working to translate their findings to patient care in the clinic and
translational/clinical investigators working to improve the outcome for patients with pancreatic cancer. We will
support highly qualified investigators who are new to the field of pancreatic cancer with a focus on early career
or mid-career investigators transitioning to work in this area.
The CEP is led by Jonathan Serody MD Associate Director for Translational Science at the Lineberger
Comprehensive Cancer Center and Elizabeth Thomas Professor of Medicine, Microbiology and Immunology.
The co-leaders are supported by the CEP Advisory Committee (CEPAC) that is chaired by the co-leaders and
includes Melissa Troester, PhD (Population Sciences), Anne Menkens, PhD (Administration), Antonio Baines
PhD (CEP Minority Advisor, NCCU), Albert Baldwin, PhD (Director DRP), and Andrea Hayes-Jordan (Pediatric
Surgery) and our patient advocates. Applicants will be selected from the highly qualified pool of investigators at
the University of North Carolina Chapel Hill and North Carolina Central University an Historic Black College and
University in Durham NC which has a strong scientific relationship with the Lineberger Comprehensive Cancer
Center and has a large African American and Latino population of students and postdoctoral fellows. Recruitment
of underrepresented minorities, disabled individuals, and women to pancreatic research will be emphasized and
will be the focus of Dr. Baines’s efforts on the CEPAC.
Financial support will be for an initial period of one year, that will be renewable if there has been appropriate
translational progress. We will collaborate with our partner institutions to strengthen multi-institutional
collaborations as the CEP matures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UNC Immunotherapy Training Grant (IM-TAG)
-
批准号:10767617
-
项目类别:
-
资助金额:$16.51万
-
财政年份:2023
-
负责人:Jonathan S. Serody
-
依托单位:
SToP Cancer SPORE: Career Enhancement Program
-
批准号:10705618
-
项目类别:
-
资助金额:$8.48万
-
财政年份:2022
-
负责人:Jonathan S. Serody
-
依托单位:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
-
批准号:10297917
-
项目类别:
-
资助金额:$65.59万
-
财政年份:2021
-
负责人:Jonathan S. Serody
-
依托单位:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
-
批准号:10653130
-
项目类别:
-
资助金额:$69.37万
-
财政年份:2021
-
负责人:Jonathan S. Serody
-
依托单位:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
-
批准号:10470834
-
项目类别:
-
资助金额:$65.59万
-
财政年份:2021
-
负责人:Jonathan S. Serody
-
依托单位:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
-
批准号:9403099
-
项目类别:
-
资助金额:$54.38万
-
财政年份:2017
-
负责人:Jonathan S. Serody
-
依托单位:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
-
批准号:9918441
-
项目类别:
-
资助金额:$54.38万
-
财政年份:2017
-
负责人:Jonathan S. Serody
-
依托单位:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
-
批准号:9528655
-
项目类别:
-
资助金额:$54.38万
-
财政年份:2017
-
负责人:Jonathan S. Serody
-
依托单位:
Targeting CCR7 for the Prevention/Treatment of GvHD
-
批准号:8372352
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
-
批准号:8273863
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
-
批准号:8468145
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
-
批准号:9024463
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
-
批准号:8626365
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Targeting CCR7 for the Prevention/Treatment of GvHD
-
批准号:8502756
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Targeting CCR7 for the Prevention/Treatment of GvHD
-
批准号:8669156
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
-
批准号:8828124
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2012
-
负责人:Jonathan S. Serody
-
依托单位:
Modeling TH17 Cells in Acute GVHD
-
批准号:8124088
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2010
-
负责人:Jonathan S. Serody
-
依托单位:
Treg Migration in GVHD
-
批准号:7890814
-
项目类别:
-
资助金额:$13.67万
-
财政年份:2009
-
负责人:Jonathan S. Serody
-
依托单位:
CLINICAL TRIAL: LCCC 0418: PHASE I/II MULTIEPTITOPE DENDRITIC CELL VACCINE IN B
-
批准号:7716825
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:Jonathan S. Serody
-
依托单位:
LCCC 0310 DENDRITIC CELL VACCINE GIVEN WITH TRASTUZUMAB AND VINORELBINE
-
批准号:7625547
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2006
-
负责人:Jonathan S. Serody
-
依托单位:
海外基金